Shares of the drug-maker Healthcare gained about 5% on Thursday after Zydus Cadila received final approval from the US health regulator to market antipsychotic Ziprasidone Hydrochloride capsules in the American market in strengths of 20 mg, 40 mg, 60 mg, and 80 mg.
The stock of Cadila healthcare rose as much as 5.09% to the day’s high of Rs 486.5 on BSE. The Nifty Pharma index gained 1.29% at 8,727.4 points and was the biggest gainer today led by the upsurge in Cadila shares. Other pharma shares which also advanced today are Divi’s Lab (up 2.66%), Sun Pharma (up 2.18%), Lupin (up 1.74%), Aurobindo Pharma (up 1.29%) and Wockhardt Pharma (up 1.27%).
The capsules will be manufactured at the group’s formulations manufacturing facility at the Pharma SEZ, Ahmedabad, Zydus Cadila said.
Meanwhile, Indian stock market opened higher on Wednesday tracking Asian stocks which edged up in the early trade today. BSE Sensex rose over 100 points to open at 31,673.44 points and NSE Nifty gained 29 points to open at 9,881.2 points.
The buying in the shares of heavyweight companies Infosys, ITC, TCS, Sun Pharmaceuticals and Reliance Industries led the benchmark indices to trade in green. But, within minutes of trading both the benchmark indices pared early morning gains with the Sensex trading up 0.11% at 31,602.64 points and the broader Nifty 50 trading 0.15% higher at 9,867.45 points.